Search the Community
Showing results for tags 'prognosis and mortality'.
Found 1 result
Revised European Scleroderma (SSc) Trials and Research Group Activity Index is the best predictor of short-term severity accrual. The adjusted mean EUSTAR-AI has the best predictive value for disease progression and development of severe organ involvement over time in SSc. PubMed, Ann rheumatologist Dis, 08/17/2019. (Also see Prognosis and Mortality) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.